Table 4. Some Topical Drugs for Atopic Dermatitis (cont.) Drug. Table 4. Some Topical Drugs for Atopic Dermatitis Drug



Similar documents
TOPICAL TREATMENTS. for psoriasis NATIONAL PSORIASIS FOUNDATION. » Over-the-counter products» Combination agents» + more

South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina

AETNA BETTER HEALTH Prior Authorization guidelines for Step Therapy

Evidence-Based Review of Topical Treatments for Psoriasis. Maryann Mikhail and Noah Scheinfeld, MD

Topical steroids are available in a

Foam: A Unique Delivery Vehicle for Topically Applied Formulations

TOPICAL THERAPY. ADVANTAGES - increased dose of medication to affected area. - reduced systemic side effects and toxicity

Learn to Like the Lichens: Lichen Sclerosus, Lichen Simplex Chronicus, and Lichen Planus

PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL

Guidelines of care for the management of psoriasis and psoriatic arthritis

Frequency of application of topical corticosteroids for atopic eczema

Prescribing advice for the management and treatment of psoriasis

Scottish Medicines Consortium

Pharmacologyonline 1: (2010) Newsletter Shah et al.

D.RIGOPOULOS, D.IOANNIDES,* D.KALOGEROMITROS, S.GREGORIOU AND A.KATSAMBAS

For Mild to Moderate Plaque Psoriasis and Moderate to Severe Atopic Dermatitis

Psoriasis is a chronic skin disease

COMMON SKIN PROBLEMS Steven E. Prawer, MD, Clinical Professor of Dermatology, University of Minnesota Medical School, Minneapolis

Pimecrolimus cream (Elidel) for facial atopic dermatitis

Top 10 Psoriasis Treatment Tips

TOP TIPS FOR TREATING

Glucocorticoid Receptor Activity of a Wastewater Effluent-Dominated Stream

Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement

Pharmacy Management Drug Policy

Management of atopic eczema in children

EFFECTIVE OCTOBER Drug Formulary. For federal employees and retirees on the Federal Employees Health Benefits Program.

Key words: Psoriasis, Calcipotriol, Tazarotene. tazarotene. 16 ( 4 ) tazarotene calcipotriol ( 22 : 23-34, 2004)

Can I Use Betnovate C On My Face

Betamethasone Dipropionate Otc

Understanding your psoriasis and psoriatic arthritis medications URAC. All Walgreens specialty pharmacy locations are ACHC and URAC accredited.

SESSION F4. The Lichens: Cases of Vulvar Itching, Burning and Pain Andrea Prabhu, MD

Betamethasone Lotion For Scalp

Betamethasone Valerate For Acne

0.05 Betamethasone Or Betamethasone Dipropionate

Betamethasone Valerate Cream

Betamethasone Valerate Cream 0.1

Betamethasone Valerate Over The Counter

Buy Betamethasone Cream Uk

Betamethasone Topical Cream

Betnovate N Cream Reviews

Betamethasone Buy Uk betamethasone lotion 0.05 betamethasone sodium phosphate oral drops gentamicin betamethasone eye drops

Betnovate N For Acne betamethasone sodium phosphate injection during pregnancy betnovate crema para bebes betamethasone lotion 0.

Buy Betamethasone Eye Drops

Betnovate N For Acne Scars

Betnovate C For Acne Scars

Gentamicin Betamethasone Eye Drops

Betnovate 1 Mg/g Crema Precio

Betamethasone Ointment Philippines

Betamethasone Valerate Cream Bp For Phimosis

Betnovate Crema Topica Para Sirve

Betamethasone Valerate Cream Hemorrhoids

Betnovate Crema Composicion

Betnovate Crema Composicion

Betnovate For Acne Scars

Fungsi Krim Elocon Mometasone Furoate

Atopic eczema is a relapsing and remitting disease.

Can Betnovate Be Used On The Face

Betamethasone Dip 05 Cream

MISSISSIPPI DIVISION OF MEDICAID Pharmacy & Therapeutics Committee Meeting Woolfolk Building Conference Center East, Room 145 Jackson, MS

Cream / Ointment / Gel Product List Sr. No. BRAND NAME COMPOSITION

MEDICATION GUIDE. PROTOPIC [pro-top-ik] (tacrolimus) Ointment 0.03% Ointment 0.1%

Evolving Issues and New Treatment Approaches to Psoriasis:

Betamethasone Valerate Cream.05

Atopic Dermatitis/Eczema

Georgia Department of Community Health. Department of Community Health 2 Peachtree Street - 5 th Floor Board Room Atlanta, Georgia 30303

March Management of atopic eczema in primary care. A national clinical guideline. Scottish Intercollegiate Guidelines Network

TOPICAL TREATMENTS FOR PSORIASIS

Drug Formulary Update, July 2014 Commercial and State Programs

Statement of Principles concerning PRURITUS ANI

全 球 银 屑 病 治 疗 药 物 市 场 研 究 报 告 Psoriasis Drugs - A Global Strategic Business Report

The prevalence of psoriasis in the

Betamethasone Lotion 0.1

A t f e t r e r th t is s lec e t c u t re r e t h t e e st s u t den e t t sh s ould b e e a b a le e t o t :

Betnovate Skin Cream Review

Scalp Psoriasis. A positive approach. to psoriasis and. psoriatic arthritis

EFFECTIVE JULY Drug Formulary

PSORIASIS AND ITS. Learn how vitamin D medications play an important role in managing plaque psoriasis

Elocon Cream W White

Guidelines of care for the management of psoriasis and psoriatic arthritis

Psoriasis and lichen planus. Department of Dermatology SRM MCH & RC

DERMATITIS ECZEMA JOHN L. BEZZANT, M.D.

Betamethasone 0.05 Cream Buy

Treatment options a simple guide

For more information, please contact the National Psoriasis Foundation at or

BJD British Journal of Dermatology. Summary SYSTEMATIC REVIEW

Oxford University Hospitals. NHS Trust. Dermatology Department Frontal Fibrosing Alopecia. Information for patients

Guidelines of care for the management of psoriasis and psoriatic arthritis

Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong

CAUTION required in distinguishing true hypogonadism from symptoms naturally occurring with age (often multifactorial).

A Guide to Dermatology in Primary Care. Royal United Hospital Bath NHS Trust

Facial Use of Low Potency Steroids With Anti-microbials and Retinoids

Atopic eczema in children

NEW ZEALAND DATA SHEET BETNOVATE -C CREAM and OINTMENT

Public Forum on Psoriasis National Series

Formulary Review of Therapeutic Alternatives for Atopic Dermatitis: Focus on Pimecrolimus

FastTest. You ve read the book now test yourself

An Update on Scalp Psoriasis

Scalp psoriasis: European consensus on grading and treatment algorithm

Department of Dermatology, Churchill Hospital PUVA Treatment

PRODUCT MONOGRAPH. HydroVal. (Hydrocortisone Valerate USP) Cream & Ointment 0.2 % Topical Corticosteroid

Transcription:

Table 4. Some Topical Drugs for Atopic Dermatitis Drug Vehicle CALCINEURIN INHIBITORS Pimecrolimus 1% adel (Novartis) Tacrolimus 0.03% Protopic (Astellas) Tacrolimus 0.1% Protopic (Astellas) CORTICOSTEROIDS Super-High Potency Betamethasone dipropionate augmented 0.05% int. lotion, gel Diprolene (Schering-Plough). gel Clobetasol propionate 0_059'0 Cormax (Watson) Ciao( (Gaiderma) Olux (Connetics Corp) Temovate (GSK) Fluocinonide 0.1% Vance (Megicis) Halobetasol propionate 0.05% Uttravate (Ranbaxy) High Potency Amcinonide 0.1% Betamethasone dipropionate 0.05% augmented aprolene AF (Schering-Plough) Beta methasone dipropionate 0.05 Desoximetasone 0.25% Topicort (Taro) Topicort 0.05% (Taro) Diflorasone diacetate 0.05% Fluocinonide 0_05% Halcinonide 0.1% Ha log (Ranbaxy) Mometasone furo ate al% Docon (Schering-Plough) Triamcinolone acelonide 0.5%., gel, foam. soln, soln lotion, spray. shampoo foam, soin,, gel,,, gel,, gel, gel gel gel,, soln. Table 4. Some Topical Drugs for Atopic Dermatitis (cont.) Drug Vehicle Medium-High Potency Amcinonide 0.1%. lotion Betamethasone dipropionate 0.05c.% Betamethasone valerate 0.19 Diflorasone diacetate 0.05% Fluocinonide emollient 0.05% Fluticasone propionate 0_005% Cutivate (PharmDerm) Triamcinolone acetonide 0.19/0 Triamcinolone acetonide 0.5% Medium Potency Betamethasone valerate 0.12% timid (Stiefel Labs) Flu ocinolone acetonide 0.0259'0 valerate 0.2% Westcort (Ranbaxy) Mometasone furoate 0.1% Elocon (Schering-Plough) Triamcinolone acetonide 0.19'0 Medium-Low Potency Betamethasone dipropionate 0.05% Betamethasone valerate 0.1% Desonide 0.059'0 Desowen (Galderma) 0_025% Flurandrenolide 0_05% Cordran (Aqua) Cordran SP (Aqua) Fluticasone propionate 0_05% Cutivate (PharmaDerm) foam Dint, lotion, lotion lotion lotion

BRAND NAME GENERIC NAME BRAND NAME GENERIC NAME CLASS 2 - Potent (cont.) CLASS 5 - Lower Mid-Strength (cont.) Halog Ointment/Cream, 0.1% Halcinonide DesOwen Lotion, 0.05% Desonide Lidex Cream/Gel/Ointment, 0.05% Psorcon Cream, 0.05% Fluocinonide Diflorasone diacetate Locoid Cream/Lotion/Ointment/ Solution, 0.1% Pandel Cream, 0.1% Topicort Cream/Ointment, 0.25% Desoximetasone Synalar Cream, 0.03/0.01% Topicort Gel, 0.05% Desoximetasone Westcort Cream, 0.2% valerate CLASS 3 - Upper Mid-Strength Cutivate Ointment, 0.005% Fluticasone propionate Lidex-E Cream, 0.05% Fluocinonide Luxiq Foam, 0.12% Betamethasone valerate Topicort LP Cream, 0.05% Desoximetasone CLASS 4 - Mid-Strength Cordran Ointment, 0.05% Flurandrenolide Elocon Cream/Lotion, 0.1% Mometasone furoate Kenalog Cream/Spray, 0.1% Triamcinolone acetonide Synalar Ointment, 0.03% Westcort Ointment, 0.2% valerate CLASS 5 - Lower Mid-Strength Capex Shampoo, 0.01% Cordran Cream/Lotion/Tape, 0.05% Flurandrenolide CLASS 6 - Mild Aclovate Cream/Ointment, 0.05% Derma-Smoothe/FS Oil, 0.01% Desonate Gel, 0.05% Synalar Cream/Solution, 0.01% Verdeso Foam, 0.05% CLASS 7 - Least Potent Cetacort Lotion, 0.5%/1% Cortaid Cream/Spray/Ointment, 1% Hytone Cream/Lotion, 1%/2.5% Micort-HC Cream, 2%/2.5% Nutracort Lotion, 1%/2.5% Synacort Cream, 1%/2.5% Alclometasone dipropionate Desonide Desonide Cutivate Cream/Lotion, 0.05% DermAtop Cream, 0.1% Fluticasone propionate Prednicarbate 12 National Psoriasis Foundation topical treatments 13

THE MERCK MANUALS ONLINE MEDICAL LIBRARY FOR HEALTHCARE P R O F E S S I O N A L S SECTION Dermatologic Disorders SUBJECT Principles of Topical Dermatologic Therapy TOPIC Principles of Topical Dermatologic Therapy RELATIVE POTENCY OF SELECTED TOPICAL CORTICOSTEROIDS CLASS* DRUG I II III IV V VI VII Betamethasone dipropionate 0.05% ment Clobetasol propionate 0.05% or ment Diflorasone diacetate 0.05% ment Halobetasol propionate 0.05% or ment Amcinonide 0.1% ment Betamethasone dipropionate 0.05% Betamethasone dipropionate 0.05% ment Desoximetasone 0.25%, 0.05% gel, or 0.25% ment Diflorasone diacetate 0.05% ment Fluocinonide 0.05%, gel, ment, or solution Halcinonide 0.1% Mometasone furoate 0.1% ment Amcinonide 0.1% or lotion Betamethasone dipropionate 0.05% Betamethasone dipropionate 0.05% lotion Betamethasone valerate 0.1% ment Diflorasone diacetate 0.05% Fluocinonide 0.05% Fluticasone propionate 0.005% ment Halcinonide 0.1% ment or solution Triamcinolone acetonide 0.1% ment 0.025% ment Flurandrenolide 0.05% ment Mometasone furoate 0.1% or lotion Triamcinolone acetonide 0.1% ment Triamcinolone acetonide 0.1% Betamethasone valerate 0.1% Desonide 0.05% ment 0.025% Flurandrenolide 0.05% Fluticasone propionate 0.05% butyrate 0.1%, ment, or solution valerate 0.2% or ment Triamcinolone acetonide 0.1% lotion or 0.025% ment Alclometasone dipropionate 0.05% or ment Betamethasone valerate 0.1% lotion Desonide 0.05% 0.01% or solution Flumethasone pivalate 0.03% Triamcinolone acetonide 0.1% Triamcinolone acetonide 0.025% or lotion 1% or 2.5%, 1% or 2.5% lotion, or 1% or 2.5% ment acetate (1% or 2.5%, 1% or 2.5% lotion, or 1% or 2.5% ment) and pramoxine hydrochloride 1% *Class I is the most potent, and class VII is the least potent. Potency depends on many factors, including the drug s characteristics and concentration and the base in which it is used.

TOPICAL STEROIDS Alclometasone dipropionate 0.05% Aclovate (crm, ) 0.01% Synalar (soln) base or acetate 0.5% Cortisporin* (crm) Betamethasone valerate 0.12% Luxiq (foam) Clocortolone pivalate 0.1% Cloderm (crm) Desonide 0.05% Desonate (gel) DesOwen (crm, lotion, ) Verdeso (foam) Topicort-LP (emollient crm) 0.01% Derma-Smoothe/FS (oil) Capex (shampoo) Amcinonide 0.1% Betamethasone dipropionate, augmented 0.05% Diprolene AF (emollient crm) Diprolene (lotion) Topicort (gel) Betamethasone dipropionate, augmented 0.05% Diprolene (, gel) NOTES Classification of topical steroid preparations by potency LOW POTENCY base or acetate 1% Cortisporin* () Hytone (crm, ) U-cort (crm) Vytone* (crm) INTERMEDIATE POTENCY 0.025% Synalar (crm, ) Flurandrenolide 0.025% Cordran-SP (crm) Cordran () Flurandrenolide 0.05% Cordran-SP (crm) Cordran (lotion, ) Fluticasone propionate 0.005% Cutivate () Fluticasone propionate 0.05% Cutivate (crm, lotion) probutate 0.1% Pandel (crm) HIGH POTENCY Desoximetasone 0.25% Topicort (emollient crm, ) Diflorasone diacetate 0.05% Psorcon e (emollient crm, emollient ) Fluocinonide 0.05% Lidex (crm, gel,, soln) Lidex-E (emollient crm) SUPER HIGH POTENCY Clobetasol propionate 0.05% Clobex (lotion, shampoo, spray) Cormax (, scalp application) Olux (foam) Olux-E (foam) Temovate (crm, gel,, scalp application) Temovate-E (emollient crm) *Indicates that the product has more than one active ingredient. Also available as a ally. Also available as a or ment ally. Also available as a, ment, or lotion ally. base or acetate 2.5% Anusol-HC (crm) Hytone (crm, ) Triamcinolone acetonide 0.025% Kenalog (crm, lotion, ) butyrate 0.1% Locoid (crm,, soln) Locoid Lipo (crm) valerate 0.2% Westcort (crm, ) Mometasone furoate 0.1% Elocon (crm, lotion, ) Prednicarbate 0.1% Dermatop (emollient crm, ) Triamcinolone acetonide 0.1% Kenalog (crm, lotion) Triamcinolone acetonide 0.2% Kenalog (aerosol) Halcinonide 0.1% Halog (crm,, soln) Triamcinolone acetonide 0.5% Kenalog (crm) Fluocinonide 0.1% Vanos (crm) Flurandrenolide 4mcg/sq cm Cordran (tape) Halobetasol propionate 0.05% Ultravate (crm, ) The classification is based on vasoconstrictor assays and clinical studies. Potency varies according to the corticosteroid, its concentration, and the vehicle. In general, corticosteroids in lotions, s, gels, and ments are increasingly more potent due to increased absorption from these vehicles. Absorption is increased by prolonged therapy, large areas of skin damage, and the use of occlusive dressings which may cause an increase in the incidence of side effects. (Rev. 8/2009)